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Antibodies against hepatitis E virus (anti-HEV) were found in 248 
Swedish and Danish patients between 1993 and 2007. Most 
patients were symptomatic and tested for anti-HEV due to travel 
abroad. Among patients with known country of infection, most 
were infected in Asia, mainly on the Indian subcontinent. However, 
29 patients were infected in Europe, nine of these had HEV IgM 
and/or HEV RNA in serum. In sera from 65 of 141 tested patients 
HEV RNA could be detected, and 63 strains could be typed by 
limited sequencing within ORF2. HEV RNA was found in sera 
from 71% of the patients with HEV IgM and IgG and in 18% of 
the patients with only detectable HEV IgG. It was also found up to 
three weeks after the onset of disease in 67% of the patients with 
known date of onset. Patients infected in Europe were infected 
by genotype 3, and were older than those infected by genotype 
1 (mean age 55.3 vs 30 years, p<0.001). Since it is known that 
genotype 3 can infect domestic pigs, HEV strains from 18 piglets in 
17 herds in Sweden and Denmark were sequenced.  Phylogenetic 
analyses of the genotype 3 strains showed geographical clades 
and high similarity between strains from patients and pigs from 
the same area. There are thus autochthonous hepatitis E cases 
in Scandinavia, and there are probably many undiagnosed ones. 
Patients with hepatitis of unknown etiology should therefore be 
investigated for anti-HEV even if they have not been outside Europe, 
since infections acquired from pigs or other animals should be 
taken into consideration.
Introduction
Hepatitis E virus (HEV) is a non-enveloped positive-stranded 
RNA virus of 27-34 nm in diameter [1]. It is the only member 
of the genus Hepevirus in the family Hepeviridae. The genome is 
approximately 7.2 kb in length and encodes three open reading 
frames, from ORF1 to ORF3. ORF1 encodes for enzymes important 
for replication and transcription, ORF2 encodes for a capsid protein 
and ORF3 for a small protein of 122 or 123 amino acids that 
interacts with cellular proteins and contributes to viral replication. 
There is only one serotype but based on genetic diversity HEV 
strains are classified into four genotypes designated with Arabic 
numerals 1 to 4. The genotypes are further divided into up to 
seven subtypes designated with Roman characters a – g, each with 
distinct geographical distribution [2]. Genotypes 1 and 2 only infect 
humans, mainly in Asia, and Africa, where they are endemic and 
may cause large outbreaks. Genotype 2 has been found causing 
outbreaks in Mexico and Africa. Strains of the other two genotypes, 
3 and 4, have been shown to infect not only humans, but also 
domestic pigs, wild boars, deer, and other mammals. These two 
genotypes have not been reported to cause outbreaks. In endemic 
countries, as India, genotype 1 infects humans, while HEV isolates 
from swine belong to genotype 3 or 4 [3]. However, genotype 3 
strains have also been isolated from sporadic human cases of 
hepatitis E, and from domesticated pigs in several European 
countries, in the United States (US) and in Japan, while genotype 
4 strains have been found in humans and pigs exclusively in Asia, 
as China, Taiwan, Japan and Vietnam [4-7]. 
Hepatitis E is transmitted mainly by the faecal-oral route, usually 
through contaminated drinking water. Usually, the infection is 
self-limited, although some persons develop fulminant hepatitis. 
In pregnant females the illness is particularly severe with up to 
20% fatality rate in the third trimester, but it may be even higher 
in patients with underlying chronic liver disease [8,9]. Chronic 
hepatitis E infections have also been described in transplant 
patients on immunosuppressive treatment [10].  
Hepatitis E was previously considered to mainly affect 
the inhabitants of or travellers to Asia and Africa, due to high 
endemicity in these parts of the world. However, in recent years 
there have been several reports on autochtonous hepatitis E cases 
in Europe, including United Kingdom (UK), the Netherlands and 
France [6,7,11,12], and also in the US, New Zealand and Japan 
[4,13,14]. There have also been increasing numbers of reports on 
high seroprevalence in Europe and the US. Antibodies againts HEV 
(anti-HEV) were found in 17% of blood donors in the UK and in 
France, in 21-33% of blood donors and 50% of farmers in Denmark 
and 5 to 9% of the general population and 13% of veterinarians 
in Sweden [11,15-18]. These data indicate that there is a high 
prevalence of hepatitis E infections also in Europe, albeit most 
infections are subclinical and most of them may be zoonotic. The 
study presented here was performed to investigate which genotypes 
of HEV were imported to Denmark and Sweden between 1993 and 
2007, and to find out if there were any endemic HEV strains and, 
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if so, to determine their relation to HEV strains obtained from pigs 
in these countries. 
Materials and methods 
Identification of human cases with hepatitis E
Patients with a recent travel history and with clinical signs of 
hepatitis not caused by hepatitis A, B, C or D virus were investigated 
for hepatitis E at the Swedish Institute for Infectious Disease 
Control (Smittskyddsinstitutet, SMI), Solna, Sweden. Sera from 
these patients were tested for HEV IgG and IgM by a kit using two 
recombinant HEV antigens corresponding to structural region of 
the HEV (Diagnostic Biotechnology, Singapore). Between 1993 
and 2006, all samples were also tested for HEV IgG and IgM by 
using the until then commercially available ELISA kits from Abbott 
Laboratories (Abbott Laboratories, Chicago, IL). All reactive sera 
were tested for HEV RNA by PCR and the amplified fragments 
were sequenced. 
Identification of pigs infected by HEV
HEV RNA was isolated and sequenced from 18 HEV strains from 
pigs. The strains were obtained from two HEV prevalence studies 
(Breum, unpublished; Widén et al., unpublished). Eight strains 
were from piglets from seven Danish pig herds and 10 strains were 
from piglets from 10 Swedish herds.  
RNA extraction
HEV RNA was extracted from 200 ul serum from humans or 
faecal suspension from pigs using QIAamp UltraSense Virus Kit 
(Qiagen, GmbH, Germany) as described by the manufacturer. Five 
ul RNA were used for cDNA synthesis in 20 ul mix containing 5 
ul 5X First Strand buffer (Invitrogen, Life Technologies, Carlsbad, 
CA), 10 mM DTT (Invitrogen, Life Technologies, Carlsbad, CA), 
0.5 mM dNTP (Thermo Scientific, Abgene®, Epsom, UK), 100 U 
Superscript II Reverse Transcriptase (Invitrogen, Life Technologies, 
Carlsbad, CA), 0.5 ul RNasin (Promega, Madison, US) and 0.1 U 
random hexamere primers (Roche Diagnostics, GmbH, Germany). 
Reverse transcription was performed at room temperature for 15 
minutes and then at 42°C for two hours.
Nested PCR in the RdRp domain of ORF1 region
A nested PCR was carried out in a 50 ul reaction with 5 ul cDNA, 
0.06 ul of 0.2 mM of each primers ISP-4232 and EAP-4576 [19], 
5 ul 10X Taq.buffer general, 2 mM MgCl2 (Applied Biosystems, 
Roche Molecular Systems, New Jersey, US), 0.2 mM dNTP (Thermo 
Scientific, Abgene®, Epsom, UK) and 4 U Taq polymerase (Thermo 
Scientific, Abgene®, Epsom, UK). The PCR reaction was carried 
out for 40 cycles with denaturation at 94°C for 20s, annealing at 
60°C for 30s and extension at 72°C for 60s. The second round 
reaction was carried out similarly but with 5 ul first round product 
instead of cDNA, 2.5 mM MgCl and 0.06 ul of 0.2 mM of each 
primer ISP-4232 and IAP-4561 [19].
Nested PCR in the ORF2 region
Two different nested PCRs for amplification of the ORF2 region 
were performed. PCR:1 was carried out in a 50 ul reaction with 
10 ul cDNA, 0.1 ul of 0.2 mM primer HE110 [14], 0.119 ul of 
0.2 mM primer HE041 (14), 5 ul 10X Taq.buffer general, 2.5 mM 
MgCl2, 0.2 mM dNTP, 6 U Taq polymerase. The PCR reaction was 
carried out for 40 cycles of denaturation at 94°C for 20s, annealing 
at 56°C for 20s and extension at 72°C for 60s. The second round 
reaction was carried out with 5 ul PCR product, primers HE110 
and HE3159 [20] with reagents and cycling as in the first round. 
T a b l e  2
Hepatitis E virus (HEV) RNA detection in serum samples from Swedish and Danish patients (1993-2007) with anti-HEV IgM 
and IgG or anti-HEV IgG only
Patient 
origin N
Anti-HEV
IgM + IgG
Anti-HEV
IgG only HEV RNA positive (%)
HEV RNA in IgM + IgG 
positive sera
HEV RNA in IgG only 
positive sera
Number of 
sequenced strains
Sweden 82 44 38 44 (57 %) 38 (86 %) 9 (24 %) 44
Denmark 59 36 23 21 (36 %) 19 (53 %) 2 (9 %) 21
Total 141 80 (57 %) 61 (43 %) 65 (46 %) 57 (71 %) 11 (18 %) 63 (97 %)
T a b l e  1
Age and sex distribution of patients from Sweden and Denmark (1993-2007) with serological markers against hepatitis E virus (HEV)
Number of patients with anti-HEV IgM Number of patients with anti-HEV IgG only
Sweden Denmark Sweden Denmark
Age M F M F Sub-total M F M F Sub-total Total
0-9 0 0 2 0 2 0 1 2 0 3 5
10-19 8 1 3 1 13 2 2 3 0 7 20
20-29 13 8 8 6 35 8 4 9 2 23 58
30-39 4 4 6 2 16 7 3 24 7 41 57
40-49 4 0 2 1 7 9 4 14 3 30 37
50-59 0 1 1 1 3 5 5 11 10 31 34
60-69 2 3 3 0 8 2 5 9 2 18 26
>70 1 0 0 0 1 3 3 1 3 10 11
Total 32 17 25 11 85 36 27 73 27 163 248
M = male, F = female  
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PCR:2 was carried out with with 5 ul cDNA, and primers HE3156 
and  HE3157 [20]. Two microliters of this product were further 
amplified with primers HE3158 and HE3159 [20].
Sequencing the ORF2 region
The amplified products were purified using the EZNA Cycle 
Pure Kit (Omega Bio-Tek, GA, US) according to the manufacturers 
instructions. The sequencing reaction was made with BigDye 
Terminator Cycle Sequencing Ready reaction kit version 3.1 
(Applied Biosystem, CA, US). The ABI PRISM 3100 genetic 
analyser (Applied Biosystems, CA, US) was used for electrophoresis 
and data collection.
Phylogenetic analysis
The sequences obtained were analysed in the programs SeqMan 
and Sequencing Analysis. Eighty-four analysed sequences were 
aligned with the corresponding region of 554 sequences obtained 
from GeneBank. The phylogenetic analysis was carried out with the 
T a b l e  4
Reported country of infection and infecting hepatitis E virus (HEV) genotype of Swedish and Danish patients (1993-2007) 
with anti-HEV IgM and IgG or with only detectable anti-HEV IgG
Country/region of 
infection
Number of 
samples
Number of 
samples from 
patients with 
anti-HEV IgM
Number of 
samples from 
patients with 
anti-HEV IgG 
only
HEV RNA positive 
samples/ tested from 
patients with anti- 
HEV IgM
HEV RNA positive 
samples/tested 
from patients with 
anti-HEV IgG only
Geno-type 1 Geno-type 3
Europe
Sweden
Sweden*
Denmark
Bulgaria
Canary Islands
Spain**
Italy
Majorca 
Greece
Serbia
Poland
Russia
Subtotal
8
1
7
1
2
2
2
1
1
2
1
1
29
1
1
2
0
0
2
0
1
0
1
0
0
8
7
0
5
1
2
0
2
0
1
1
1
1
21
1/1
0
2/2
0
0
1/1
0
1/1
0
1/1
0
0
6/6
1/5
1/1
0/1
0/1
0/1
0
0/1
0
0
0
1/1
0
3/11
0
1
0
0
0
0
0
0
0
0
0
0
1
2
0
2
0
0
1
0
1
0
1
0
0
7
Asia 2 1 1 0/1 0/1 0 0
Afghanistan
Bangladesh
India
Nepal
Pakistan
Thailand
Singapore
Indonesia
Subtotal
5
16
34
5
15
6
1
1
85
3
12
24
4
9
0
0
0
53
2
4
10
1
6
6
1
1
32
1/3
8/11
19/22
4/4
8/9
0/0
0
0
40/50
0/2
1/3
4/9
0
2/3
0/3
0
0
7/21
1
9
21
4
10
0
0
0
45
0
0
0
0
0
0
0
0
0
Middle East
Syria
Turkey
Iraq
Iran
Subtotal
1
1
1
1
4
0
0
1
0
1
1
1
0
1
3
0
0
0/1
0
0/1
0/1
0/1
0
0
0/2
0
0
0
0
0
0
0
0
0
0
Africa
Tanzania
Somalia
Ethiopia
Egypt
Subtotal
1
1
1
1
4
0
1
0
0
1
1
0
1
1
3
0
0/1
0
0
0/1
1/1
0
0
0
1/1
1
0
0
0
1
0
0
0
0
0
South America
Dominican Republic
Brazil
2
1
1
0
1
1
0
0
0/1
0
0
0
0
0
Country not reported 122 21 101 8/22 1/23 9 0
Total 248 85 163 54/80 11/61 56 7
* Contact case to an infected relative from Pakistan
** The numbers for Spain exclude Canary Islands and Majorca which are listed separately
T a b l e  3
Presence of hepatitis E virus (HEV) RNA in serum of 
patients from Swedish and Denish patients (1993-2007) 
in relation to onset of disease when this information was 
known
Number of 
weeks after 
onset of 
disease
Number of 
samples
HEV RNA detection 
in ORF 1/number 
tested (%)
HEV RNA detection 
in ORF 2/number 
tested (%)
1 53 35 (66 %) 30 (57%)
2 6 6 (100%) 3 (50 %)
3 3 2  (67%) 1 (33 %)
4 8 2 (25 %) 3 (38 %)
5 4 2 (50%) 2 (50%)
>6 10 1 (10%) 0
Total 84 48 (57 %) 39 (46 %)
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PHYLIP package version 3.65 [21]. Evolutionary distances were 
using the F84 algorithm in the DNADIST program with transition/
transversion ratio of 4.29. Phylogenetic trees were constructed 
using UPGMA and Neighbor-joining method in the NEIGHBOR 
program in the PHYLIP package. The trees were visualized using 
the program Tree View, version 1.6.6.  Bootstrap analysis of 
1,000 replicas was perfomed with the programs SEQBOOT and 
CONSENSE in the PHYLIP package.
Results 
There was no significant difference in age and sex distribution 
between the patients from Sweden compared with those from 
Denmark (Table 1). Anti-HEV IgM and IgG was found in 85 patients, 
57 (67%) of those were males. There was also a predominance of 
males, 109/163 (67%), among patients in whom only anti-HEV IgG 
without detectable IgM was found (Table 1). The mean age of the 
patients with anti-HEV IgM was 31.5 years, while those with only 
detectable anti-HEV IgG were older with a mean age of 43.6 years. 
HEV RNA could be detected in serum from 65 of 141 tested 
anti-HEV positive patients (Table 2). The PCR in the ORF1 region 
was more sensitive and could amplify 63 of the strains, while 51 
of the strains were amplified in the ORF2 region. HEV strains could 
be amplified in 68% of the sera from patients with IgM anti-HEV, 
as well as in 18% of sera from patients with detectable anti-HEV 
IgG only (Table 2). 
The time of onset of disease in relation to the time of sample 
collection was known for 84 patients (Table 3). All six patients 
sampled 2-3 weeks after onset had detectable HEV RNA in serum 
when ORF 1 was amplified, while only three of these patients had 
detectable HEV RNA when ORF2 was amplified. In two patients 
HEV RNA was detected as long as five weeks after onset of illness. 
The countries of infection, known for 126 (51%) of the patients, 
were mainly in Asia with India, Pakistan and Bangladesh as 
dominating countries (Table 4). Twenty-nine patients (23%) were 
infected in Europe, while the rest were infected in the Middle East, 
Africa or South America (Table 4). Six of the patients infected in 
Europe were injecting drug users (IDUs) and one case in Sweden 
was a contact of an HEV-infected relative from Pakistan [22].
The PCR amplified regions could be sequenced for 63 of the 65 
PCR amplified isolates and 56 patients were found infected with 
genotype 1, while seven were infected with genotype 3 (Table 4). 
Those with genotype 1 had all been infected in Asia and Africa, 
apart from the Swedish contact of a case from Pakistan, while all 
those with genotype 3 were infected in Europe. 
There was a predominance of males in both groups, with five 
males among the seven patients infected by genotype 3 and 43 
males among the 56 patients infected by genotype 1. The patients 
infected by genotype 3 were older than those with genotype 1. 
The mean age of patients infected with genotype 3 was 55.3 
years, while the mean age of those with genotype 1 was 30 years 
(p<0.001; unpaired t-test). 
HEV RNA could be detected in six faecal samples from six out of 
10 piglets tested (in six out of 10 Swedish breeding herds) and in 
eight samples from piglets originating from seven Danish breeding 
herds. All piglets were found infected with genotype 3. 
In the phylogenetic analysis all isolates could be allocated to 
either genotype 1 or 3 (Figure 1). It was also found that genotype 
3 could be subdivided into two major clades, here tentatively 
designated 3-I and 3-II (Figures 1 and 2b). Subtypes 3a, c, and d 
clustered in clade 3-I, while strains of subtype 3e, g, and f were 
found in clade 3-II (Figures 1 and 2b). This sequenced region of 
ORF2 was not available in GenBank for subtypes 3h and 3j. The 371 
nucleotides of the genomic region coding for the methyltransferase 
was available for these subtypes and from three genotype 3f strains 
and was compared with the corresponding region of the genotype 
3 strain from a Swedish pig (accession number EU360977). The 
nucleotide sequence of the Swedish pig strain diverged by 81–84% 
from subtype 3h and j in this region, whereas it was 88-89% similar 
to subtype 3f. Sequences of the same subtypes were similar in 88-
90% to each other and in 84-86% to the sequences of the other 
subtypes. Based on this comparison, the Swedish strains found in 
clade 3-II may belong to subtype 3f. 
Even if most genotype 1 sequences available in GenBank 
originate from India and Nepal, there was a geographical clustering 
with these strains and 1a, 1b and 1c strains from China, Japan and 
Kyrgyzstan forming one cluster, while another cluster was formed by 
1d and 1e strains from Africa (Figure 2a). In our study, the majority 
of patients infected on the Indian subcontinent were infected by 1a. 
The sequences from isolates from India and Pakistan were similar to 
strains available in GenBank from these countries and from Nepal, 
while those from patients infected in Bangladesh were found on a 
separate branch. However, one strain from a patient infected with 
1a in Tanzania was more similar to strains from India than to strains 
from Africa, and was thus an exception. 
The strains found in clade 3-I were from Asia, mainly Japan, 
South Korea and China, and the US. Two strains in our study were 
found in this clade, one was from a Swedish pig herd the other 
was from a woman infected in Serbia/Montenegro and was similar 
to a Japanese strain (AB094212). All other genotype 3 isolates 
in this study were found in clade 3-II and clustered according to 
geographical origin (Figure 2b). There were two major subclusters 
within 3-II one was formed by 3f strains from Europe the other by 
subtype 3e and 3g strains from Japan, Mongolia and Kyrgyzstan. 
There was geographical clustering also within the clade formed by 
European isolates. One branch was formed by strains from Spain 
and France, one with strains from the Netherlands and France and 
one with Swedish and Danish strains intermixed with three strains 
from Spain (Figure 2b). The isolates from one Swede and one Dane 
infected in Spain were similar to strains from Spanish pigs.  The 
strains from individuals infected in Sweden or Denmark were all 
similar to strains from Swedish and Danish pigs (Figure 2b). Pig 
strains from two Swedish breeding herds were found similar to 
Japanese and Mongolian strains within clade 3-II.      
Discussion
Hepatitis E is not considered a major public health problem in 
non-endemic countries. This study confirms that most cases of 
hepatitis E in Scandinavia are imported from Asia. However, several 
cases have been infected in Europe, which is generally regarded 
as a non-endemic region. There have been rather few reported 
cases of autochthonous hepatitis E in European countries to date 
[11,19,21], although several reports have shown a seroprevalence 
ranging from 5 to 33% in the adult population in Europe, Japan and 
the US [11,15-18]. This indicates that hepatitis E is not uncommon 
in these countries, although most infections are subclinical or 
inapparent. 
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F i g u r e  1
Phylogenetic tree based on 279 nucleotides of the capsid region of ORF 2 in 638 hepatitis E virus (HEV) strains 
The branches with strains of known subtypes are marked with the subtype designation. The accession numbers of the strains with known subtypes 
according to Lu et al. 2006 [2] are given at the nodes with lines separating strains belonging to different subtypes. The figures at the internal nodes are 
boot strap values of 1,000 replicas.
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F i g u r e  2 a
Branch formed by genotype 1 strains of the phylogenetic tree shown in Figure 1
The strains described in this study are shown in bold. The figures at the internal nodes are boot strap values of 1,000 replicas.
306-05 Sweden/India
342-05 Sweden/India
Ne146 (AB085977) Nepal
Ne055 -2000 (AB116184) Nepal
Ne045 -1999 (AB116175) Nepal
Ne038 -1999 (AB116173) Nepal
701-95 Sweden/India
195-95 Sweden/India
670-96 Sweden/India
Ne036 -2000 (AB116178) Nepal
Ne032 -2000 (AB116177) Nepal
Ne008 -2000 (AB116176) Nepal
Ne052 -2000 (AB116181) Nepal
Ne078 -2000 (AB116189) Nepal
Ne122 -2002 (AB116221) Nepal
Ne039 -2002 (AB116201) Nepal
1230-03 Denmark/Unknown
Ne107 -2002 (AB116218) Nepal
Ne105 -2002 (AB116217) Nepal
Ne117 -2002 (AB116219) Nepal
Ne054 -2000 (AB116183) Nepal
Ne057 -2000 (AB116185) Nepal
Ne016 -2002 (AB116192) Nepal
Ne015 -1999 (AB116160) Nepal
113-05 Sweden/India
233-04 Denmark/Unknown
333-08 Sweden/India
Ne135 -2002 (AB116225) Nepal
Ne056 -2002 (AB116207) Nepal
Ne036 -2002 (AB116199) Nepal
1297-07 Sweden/Bangladesh
3-07 Sweden/Nepal
20-03 Sweden/India
410-02 Sweden/India
Ne013 -2002 (AB116190) Nepal
132-04 Sweden/India
Ne059 -2000 (AB116186) Nepal
319-05 Sweden/India
1962-07 Denmark/Tanzania
118-05 Sweden/India
1099-03 Denmark/India
5-05 Sweden/Nepal
83-04 Sweden/India
1927-07 Denmark/Nepal
Ne112 (AB085967) Nepal
795-99 Sweden/India
Ne068 (AB085955) Nepal
Ne049 (AB085952) Nepal
Ne037 (AB085951) Nepal
Ne072 (AB085958) Nepal
Ne105 (AB085966) Nepal
254-98 Sweden/India
Ne080 (AB085960) Nepal
Ne033 -1999 (AB116168) Nepal
Ne068 -2000 (AB116188) Nepal
Hyderabad :1 (AF076239) India
Yamuna Nagar:1 ( AF459438) India
228-95 Sweden/India
Ne -A2 (AB085999) Nepal
TK15/92 (AF051830) Nepal
398-95 Denmark/Pakistan
HEVNE8L (D10330) Japan
M73218 Japan
Ne026 (AB085950) Nepal
290-98 Sweden/India
492-05 Denmark/Unknown
175-06 Denmark/Pakistan
708-05 Denmark/Unknown
Madras 1993 (X99441) India
689-96 Sweden/Bangladesh
470-96 Sweden/Bangladesh
1062-94 Sweden/Bangladesh
6894-93 Sweden/Bangladesh
Abb-2B (AF185822) Pakistan
Ne136a (AB085974) Nepal
Ne135 (AB085973) Nepal
386-99 Denmark/Unknown
344-05 Denmark/Unknown
583-05 Denmark/Unknown
787-05 Sweden/Pakistan
492-94 Sweden/Pakistan
Xinjiang epidemic 1986-1988 (L08816) China
HPEGENA (L25547) China
HPEORFS (L25595) China
HPECG (D11092) China
Sar-55 (AF444002) China
pSK -HEV -3 (AF444003) China
Uigh179 (D11093) Japan
osh89-3 (AY697427) Kyrgyzstan
4308-97 Sweden/Pakistan
499-98 Denmark/Unknown
821-99 Sweden/India
4745-97 Sweden/Pakistan
Ne159 (AB085985) Nepal
Nepal 7138 (AF302069) Nepal
Ne153 (AB085981) Nepal
Ne177 (AB085993) Nepal
Ne183 (AB085996) Nepal
Ne136c (AB085975) Nepal
Ne086 (AB085962) Nepal
Ne014 (AB085949) Nepal
Ne137 (AB085976) Nepal
Ne063 (AB085953) Nepal
559-94 Sweden/Contact
557-94 Sweden/Pakistan
hev037 (X98292) India
377-94 Sweden/India
Morocco :1 (AY230202) Morocco
T3 ( AY204877) Chad
a
b
c
d
e
100
93
10068
98
100
30
22
0.1
1
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F i g u r e  2 b
Branch formed by the genotype 3 strains forming branch 3-II shown in Figure 1
The human genotype 3 strains are underlined; those described in this study are in addition shown in bold. The HEV sequences from domestic pigs 
described in this study are shown in bold italic. The figures at the internal nodes are boot strap values of 1,000 replicas.
 
Swine 25604 (DQ315757) Spain
Swine 65903 (DQ315748) Spain
Swine 24404 (DQ315756) Spain
Swine 63004 (DQ315765) Spain
Swine 60604 (DQ315760) Spain
Swine 70603 (DQ315751) Spain
Swine 60504 (DQ315759) Spain
Swine 60904 (DQ315763) Spain
Swine 67204 (DQ315770) Spain
Swine 69003 (DQ315750) Spain
Swine 60804 (DQ315762) Spain
Swine 12804 (DQ315752) Spain
Swine 62904 (DQ315764) Spain
Swine 63104 (DQ315766) Spain
Swine 65103 (DQ315745) Spain
Swine 60304 (DQ315758) Spain
Swine 65203 (DQ315746) Spain
Swine 15104 (DQ315753) Spain
Swine 15204 (DQ315754) Spain
Swien FRSPP05 (EF050797) France
Swine SpswCV2 (AY323506) Spain
Swine SpswfCV5 (DQ093566) Spain
Swine SPSWSCV17 (DQ141126) Spain
Swine SPSWSCV14 (DQ141123) Spain
Swine SpswsCV4 (DQ093565) Spain
Swine SPSWFCV31 (EF523417) Spain
Human 1459 -06 Sweden/Spain
Swine SPSWFCV32 (EF523418) Spain
Swine SpswfCV3 (DQ093564) Spain
Swine SpswmCV6 (DQ093567) Spain
Swine NLSW97 (AF336296) The Netherlands
Swine NLSW82 (AF336294) The Netherlands
Swine NLSW15 (AF332620) The Netherlands
Swine FR79 (EF494704) France
Swine NLSW28 (AF336292) The Netherlands
Swine NLSW91 (AY032759) The Netherlands
Swine NLSW85 (AF336295) The Netherlands
Swine NLSW76 (AY032757) The Netherlands
Swine NLSW50 (AY032758) The Netherlands
Human 525 -07 Denmark/Spain
Swine SpswmCV7 ( DQ093568) Spain
Swine SPSWMCV11 (DQ141120) Spain
Swine 295 -08 Denmark
Swine 18004 (DQ315755) Spain
Swine 294 -07 Denmark
Swine 292 -07  Denmark
Swine 298 -07 Sweden
Human 26 -02 Sweden
Swine 284 -07 Sweden
Human 560 -05 Sweden
Swine 326 -07 Sweden
Swine 292 -08 Denmark
Human 392 -08 Denmark
Swine 289 -08 Denmark
Swine 288 -08 Denmark
Swine 291 -08 Denmark
Swine 290 -08 Denmark
Swine 296 -08 Denmark
Swine 293 -08 Denmark
Swine 325 -07 Sweden
Swine 63504 (DQ315768) Spain
Swine 63604 (DQ315769) Spain
Swine 63404 (DQ315767) Spain
Swine swX07-E1 (EU360977) Sweden
Swine 667 -05 Sweden
Swine 331 -07 Sweden
Swine 328 -07 Sweden
Human 38 -08 Denmark
Swine SPSWFCV2 (EF523412) Spain
Swine swJ8-10 (AB094235) Japan
Swine P354/1/02 ( AF503511) UK
SwineFR18 (EF494700) France
Swine swJ8-8 (AB094233) Japan
Swine swJ8-5 (AB248521) Japan
Swine swJ8-9 (AB094234) Japan
Swine swJ8-1 (AB094226) Japan
Swine swJ8-6 (AB094231) Japan
Swine swJ8-3 (AB094228) Japan
Swine swJ5-1 (AB094216) Japan
Swine swJ12-1(AB094250) Japan
Swine swJ12-3 (AB094252) Japan
Human HE -JA26 (AB194284) Japan
Swine 670 -05 Sweden
Swine 299 -07 Sweden
Swine 1970 -07 Sweden
Swine P143/11/02 ( AF503512) UK
Swine swJ791 (AB073911) Japan
Human HE -JA04 -1911 (AB248520) Japan
Human HEV -Sendai (AB093535) Japan
Swine swMN06 -C1056 (AB290313) Mongolia
Swine swMN06 -C1058 (AB290119) Mongolia
Swine swMN06 -C1054 (AB290115) Mongolia
Swine Osh 205 (AF455784) Kyrgyzstan
Swine UIAS268 (DQ061078) Russia
3 - II
e
f
g
67 66
100
68
53
48
38
45
47
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In our study HEV RNA was detected in 67% of sera sampled 
within three weeks after onset of illness from patients with this 
information known. This is in accordance with an HEV RNA 
detection rate of 56-59% in sera sampled 15 to 20 days after 
onset in Chinese patients with hepatitis E [23]. However, in our 
study HEV RNA was also detected in 18% of sera from patients with 
anti-HEV IgG only, which is an unexpectedly high frequency and has 
not been described earlier, since the presence of IgG in the absence 
of detectable IgM is considered a marker of past infection. Anti-
HEV IgG may persist for several years after infection, but whether 
lifelong immunity is conferred remains uncertain [24]. There is only 
one serotype of HEV, but it is not known if reinfections induce IgG 
response only or if also the IgM levels become elevated. It is also 
not known if there is a viremic phase during a reinfection when 
the level of IgG is low and the immune response has been elicited 
towards another HEV genotype. Since most of the patients in this 
study were from Scandinavia and it is known that there is a rather 
high seroprevalence against HEV in Sweden and Denmark [16-18] 
it is possible that individuals with low level antibodies towards 
genotype 3 when infected with genotype 1 developed disease and 
viraemia with anti-HEV IgG elevation only. 
In this study the only case infected by genotype 1 in Europe 
was epidemiologically linked to a case from Pakistan. All other 
patients infected in Europe were infected with genotype 3 strains. 
These individuals were mainly males and were 20–25 years older 
than the cases infected by genotype 1. This is in accordance with 
previous recent reports from the UK, France and Germany showing 
that genotype 3 is the autochthonous genotype of HEV, which gives 
disease mainly in males over the age of 50 [15,25]. 
Since autochthonous hepatitis E in humans in Europe has been 
caused by strains with 99–100% identity to European swine HEV 
[26], the suspected route of infection is through direct contact 
with pigs or other infected mammals or by foodborne transmission. 
Foodborne transmission was described in Japan in patients infected 
after consumption of undercooked pig liver or meat from wild 
boar or deer [27-29]. This route of infection may occur also in 
Europe since HEV has been detected in commercial pig liver sold 
in groceries and there is a high HEV seroprevalence in many pig 
herds [30,31]. Phylogenetic analysis of the genotype 3 strains 
revealed that most Asian and American strains belong to one major 
clade and that the European strains belong to another clade. There 
were also geographical clades of the genotype 3 strains, and strains 
from patients infected in Sweden and Denmark were similar to 
strains from Swedish and Danish piglets, while patients infected in 
Spain had genotype 3 strains similar to those of Spanish pigs. This 
pattern has previously not been described and enables a possible 
identification of the country of origin of the strain infecting the 
patient. This in turn may help to trace the source of infection and 
to identify a possible food item from that country. 
Antibodies to HEV have been shown to be prevalent among 
blood donors and apart from the faecal-oral and foodborne route 
HEV may be transmitted also through blood or blood products 
as has been reported from Japan, Saudi Arabia, France, and the 
UK [32-34].  HEV has also been reported to be transmitted by 
organ transplantations [35]. Some organ-recipients have developed 
chronic hepatitis E infection [10]. In our study the viraemia lasted 
for a relatively long period in most patients. Thus, transmission of 
HEV by blood or blood products may theoretically also occur in 
Sweden. Bloodborne transmission may also occur through injecting 
drug use. In our study six of the patients were IDUs among those 
with HEV IgG but no detectable HEV IgM or RNA. More than 60% 
of Swedish IDUs have anti-HEV [17], which further supports the 
conclusion that hepatitis E may be transmitted parenterally in 
this cohort of individuals. The high seroprevalence indicates that 
most probably IDUs are frequently reinfected with HEV. The IDUs 
in our study were investigated for HEV infection due to elevated 
transaminases. However, genotype 3 reinfections have been shown 
not to induce elevation of liver enzymes or detectable HEV IgM 
among patients on hemodialysis in Japan [36], but HEV RNA was 
not looked for in these patients. It is thus not known if reinfections 
with genotype 3 cause viraemia. Lack of HEV RNA in the sera from 
the anti-HEV IgG positive IDUs may either indicate that reinfection 
with genotype 3 does not give rise to viraemia, or that a continuous 
low-level exposure to HEV keeps the immune status at a level 
preventing reinfection with HEV, or that there is a long lasting 
immunity with detectable HEV IgG.
 
Hepatitis E in developed countries has a natural history that 
differs from classical hepatitis E in endemic areas. In the study 
presented here we have shown that HEV genotype 3 strains are 
indigenous in Sweden and Denmark, with high similarity between 
strains infecting humans and pigs. Prospective studies are needed 
to define the incidence of autochthonous infections in Scandinavia. 
It is also important to determine whether and how the spread 
occurs from pigs to humans and if there are other animal sources 
for zoonotic transmission of HEV, since genotype 3 appears to 
be a primarily animal virus that crosses the species barrier. In 
conclusion, hepatitis E should thus be considered in the diagnosis 
of patients with acute hepatitis, regardless of travel history.
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